Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer. (2023)

First Author: Kermorgant S

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.23.00460

PubMed Identifier: 37319388

Publication URI: http://europepmc.org/abstract/MED/37319388

Type: Journal Article/Review

Volume: 41

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 22

ISSN: 0732-183X